Baystreet Staff - Wednesday, September 30, 2026 Doseology Sciences Inc 11:41 AM EST - Doseology Sciences Inc : Announces the appointment of Kareem Baalbaki as the interim CEO, interim CFO and a director of the Company and Jeremy Wright as a director of the Company. Doseology Sciences Inc shares C.MOOD are trading off one cent at $0.15. Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=MOOD%3ACC&qmodStoryID=5905843864414510
